Atlas Trials

A Study of Niclosamide in Patients With Resectable Colon Cancer

Clinical trial NCT02687009 · TERMINATED

Trial details

NCT number
NCT02687009
Sponsor
Michael Morse, MD
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Colon Cancer
Start date
2017-11-07
Primary completion
2017-12-12
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.